Back |
home / stock / blu / blu message board
Subject | By | Source | When |
---|---|---|---|
pivotal Phase 3 trail completed, top line results | xr_biotech_consult | investorshub | 03/11/2016 5:25:22 PM |
got ep 0.45 : http://i65.tinypic.com/20z35w4.jpg | xr_biotech_consult | investorshub | 03/11/2016 3:21:22 PM |
hrhr here weee goo | xr_biotech_consult | investorshub | 03/11/2016 3:13:22 PM |
expected Prices per Patient per year 200-275 Thousand | xr_biotech_consult | investorshub | 03/05/2016 2:44:17 PM |
Peak sales expected 600m - 1b | xr_biotech_consult | investorshub | 03/05/2016 2:34:25 PM |
News out :-) | xr_biotech_consult | investorshub | 01/21/2016 1:37:52 PM |
will move up again | xr_biotech_consult | investorshub | 04/11/2015 11:17:03 AM |
target 2.50 CAD | xr_biotech_consult | investorshub | 06/20/2014 2:27:30 PM |
yea hell great, new high hunts new high | xr_biotech_consult | investorshub | 06/20/2014 2:26:16 PM |
BLU out in the blue | xr_biotech_consult | investorshub | 06/06/2014 4:58:18 PM |
Stock Tracker: Latest Bellus Health Inc (BLUSF) Headlines Escherichia Coli Infections - Pipeline Rev | Stock_Tracker | investorshangout | 03/09/2014 7:26:00 AM |
waht did i told u :-) | xr_biotech_consult | investorshub | 03/06/2014 6:01:09 PM |
chartguy89: BLUSF 0.5588 Stock Charts $BLUSF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 8:49:23 AM |
Stock Tracker: BLUSF Recent News Escherichia Coli Infections - Pipeline Review, H2 2013 M2 - Wed Nov | Stock_Tracker | investorshangout | 03/03/2014 7:09:21 AM |
chartguy89: BLUSF Stock Charts Sunday, February 23, 2014 at 10:28:22 PM $BLUSF Last: -0.0237 | chartguy89 | investorshangout | 02/24/2014 3:28:34 AM |
massive breakout will come here | xr_biotech_consult | investorshub | 01/28/2014 10:15:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON , June 28, 2023 /CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed ...
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“ BELLUS ” or the “ Company ”) today announced the positive outcome of the BELLUS shareholders (“ Shareholders ”) vote at this morning’s special meeting of the Shareholders (the “ ...
Special Meeting to be held on June 16, 2023 BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“ BELLUS ” or the “ Company ”) today announced that the Superior Court of Québec has issued an interim order authorizing, among other things, the holding o...